A detailed history of State Street Corp transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 161,492 shares of ELDN stock, worth $704,105. This represents 0.0% of its overall portfolio holdings.

Number of Shares
161,492
Previous 161,492 -0.0%
Holding current value
$704,105
Previous $426,000 5.63%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.57 - $3.12 $183,376 - $364,416
116,800 Added 261.34%
161,492 $426,000
Q1 2022

May 16, 2022

BUY
$3.06 - $4.89 $13,026 - $20,816
4,257 Added 10.53%
44,692 $176,000
Q3 2021

Nov 15, 2021

BUY
$5.94 - $8.46 $44,550 - $63,450
7,500 Added 22.77%
40,435 $250,000
Q2 2021

Aug 16, 2021

BUY
$7.62 - $11.75 $250,964 - $386,986
32,935 New
32,935 $261,000

Others Institutions Holding ELDN

About Eledon Pharmaceuticals, Inc.


  • Ticker ELDN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,756,800
  • Market Cap $60M
  • Description
  • Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...
More about ELDN
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.